SCHEMBL4906433

SCHEMBL4906433

CCN(c1nc(-c2ccc(F)c(Cl)c2)sc1C)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
TSHR P16473 1/20 0.39
LMNA P02545 3/20 0.34
ABL1 P00519 1/20 0.34
MAPT P10636 6/20 0.34
TP53 P04637 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
POLB P06746 1/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
PTPRC P08575 1/20 0.33
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33
PTPA Q15257 1/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 2/20 0.33
TSPO P30536 1/20 0.33
RARA P10276 1/20 0.33
RARB P10826 1/20 0.33
RARG P13631 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4901291 0.91 ALDH1A1 (0.39) ALDH1A1TSHRLMNAMAPTTP53
SCHEMBL4905782 0.91 ALDH1A1 (0.44) ALDH1A1TSHRLMNAABL1MAPT
SCHEMBL4908424 0.91 LMNA (0.42) ALDH1A1LMNAABL1PTPRCPTPN2
SCHEMBL4906041 0.90 ALDH1A1 (0.52) ALDH1A1TSHRLMNAABL1MAPT
SCHEMBL4895425 0.90 TRPM8 (0.39) ALDH1A1TSHRLMNAMAPTTP53
SCHEMBL4901395 0.88 ALDH1A1 (0.43) ALDH1A1TSHRLMNAABL1MAPT
SCHEMBL4899693 0.88 TP53 (0.40) ALDH1A1TSHRLMNAMAPTTP53
SCHEMBL4898066 0.87 ALDH1A1 (0.39) ALDH1A1TSHRLMNAABL1MAPT
SCHEMBL4906570 0.86 SLC6A3 (0.39) ALDH1A1TSHRLMNAMAPTTP53
SCHEMBL4894604 0.86 ALDH1A1 (0.43) ALDH1A1TSHRLMNAMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885LMNA 317/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885LMNA 319/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.